Coya Therapeutics (COYA) said Friday that Arun Swaminathan has begun his term as the company's chief executive officer.
The company said in August that Swaminathan, who was most recently Coya's chief business officer, succeeds Howard Berman, who will continue as executive chair.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.